In vivo, apolipoprotein E–deficient and LDL-receptor deficient mice, and LDL receptor–deficient apo B-100 (Ldlr−/−Apob100/100) mice are utilized to model CAVD. This evidence concerns the gene LDLR and congenital bilateral aplasia of vas deferens from CFTR mutation.